Insider Transactions in Q3 2019 at Accenture PLC (ACN)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.06%
|
$4,577
$199.12 P/Share
|
|
Sep 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102
+0.7%
|
$20,298
$199.12 P/Share
|
|
Sep 05
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.69%
|
$20,895
$199.12 P/Share
|
|
Sep 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
132
+0.52%
|
$26,268
$199.12 P/Share
|
|
Sep 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.37%
|
$16,119
$199.12 P/Share
|
|
Sep 05
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.15%
|
$16,119
$199.12 P/Share
|
|
Sep 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.49%
|
$24,278
$199.12 P/Share
|
|
Sep 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
71
+0.42%
|
$14,129
$199.12 P/Share
|
|
Sep 05
2019
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
88
+0.41%
|
$17,512
$199.12 P/Share
|
|
Aug 06
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
2,283
-2.85%
|
$429,204
$188.19 P/Share
|
|
Aug 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.06%
|
$4,488
$187.62 P/Share
|
|
Aug 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.76%
|
$20,383
$187.62 P/Share
|
|
Aug 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.81%
|
$16,082
$187.62 P/Share
|
|
Aug 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.51%
|
$26,180
$187.62 P/Share
|
|
Aug 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.4%
|
$16,269
$187.62 P/Share
|
|
Aug 05
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,330
-1.95%
|
$435,710
$187.78 P/Share
|
|
Aug 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.52%
|
$24,310
$187.62 P/Share
|
|
Aug 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.45%
|
$14,212
$187.62 P/Share
|
|
Aug 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
152
+0.14%
|
$28,424
$187.62 P/Share
|
|
Jul 29
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
2,000
-2.65%
|
$392,000
$196.95 P/Share
|
|
Jul 18
2019
|
Paula A Price Director |
SELL
Open market or private sale
|
Direct |
645
-8.76%
|
$125,130
$194.24 P/Share
|
|
Jul 17
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
8,000
-6.82%
|
$1,552,000
$194.57 P/Share
|
|
Jul 16
2019
|
Gianfranco Casati CEO-Growth Markets |
SELL
Open market or private sale
|
Direct |
5,000
-6.2%
|
$970,000
$194.35 P/Share
|
|
Jul 16
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.14%
|
$582,000
$194.29 P/Share
|
|
Jul 16
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Open market or private sale
|
Direct |
2,589
-0.77%
|
$502,266
$194.31 P/Share
|
|
Jul 16
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,255
-4.21%
|
$437,470
$194.33 P/Share
|
|
Jul 16
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
4,687
-8.18%
|
$909,278
$194.32 P/Share
|
|
Jul 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.06%
|
$4,750
$190.0 P/Share
|
|
Jul 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.75%
|
$20,330
$190.0 P/Share
|
|
Jul 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.81%
|
$16,340
$190.0 P/Share
|
|
Jul 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
138
+0.51%
|
$26,220
$190.0 P/Share
|
|
Jul 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
125
+0.17%
|
$23,750
$190.0 P/Share
|
|
Jul 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.4%
|
$16,340
$190.0 P/Share
|
|
Jul 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.44%
|
$24,320
$190.0 P/Share
|
|
Jul 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.44%
|
$14,250
$190.0 P/Share
|
|
Jul 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
149
+0.13%
|
$28,310
$190.0 P/Share
|
|
Jul 01
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
3,247
-8.24%
|
$603,942
$186.29 P/Share
|
|
Jul 01
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
2,000
-0.87%
|
$372,000
$186.25 P/Share
|